title: A case of fatal pulmonary embolism raising questions about the dosing regimen for dalteparin in the very obese.
authors.forename: Andrew
authors.initials: A
authors.lastname: Walden
authors.forename: Richard
authors.initials: R
authors.lastname: Levison
authors.forename: Sudir
authors.initials: S
authors.lastname: Singh
authors.forename: David
authors.initials: D
authors.lastname: Keeling
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D017985:Dalteparin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000150:complications / Q000401:mortality; D011655:Pulmonary Embolism / Q000150:complications / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000925:Anticoagulants; D017985:Dalteparin